Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury

A legfontosabb adatok

Ki végzi
Unity Health Toronto
Hol
Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
44 fő vett részt
Kezdés
2019. máj. 3.
Befejezés
2024. márc. 3.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • CellAegis Technologies autoRIC device
  • Best Practice Management of Traumatic Brain Injury
A regiszteradat frissítve
2024. március 15.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 13 feltétel megnézéseKevesebb

Ki vehet részt

  • Severe blunt traumatic brain injury presenting to St Michael's Hospital within 48 hours of trauma
  • Glasgow Coma Scale (GCS) less than or equal to 12
  • Presence on CT Scan of intra-cranial hematoma which adequately explains level of consciousness (epidural, subdural, subarachnoid hematomae)
  • Able to undergo intervention within 48 hours of trauma

Ki nem vehet részt

  • Unable to safely undergo ischemic conditioning of the upper extremity due to major trauma, previous surgery, known vascular disease or previous radiation treatment
  • Surgical intervention within 12 hours of presentation to hospital, excluding pressure monitor insertion
  • Pre-intervention insertion of intra-cranial pressure monitor, as surgical trauma may influence biomarker measurements
  • Pre-hospital therapeutic anticoagulation or anti-platelet agent use
  • Age <18 years
  • Lack of informed consent or withdrawal of consent, provided by legal substitute decision maker
  • Unknown timing of trauma
  • Acute significant injury (those injuries which in isolation would require admission to hospital) outside the head and neck region
  • Patient death within 24 hours of admission

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The prevention of secondary brain injury is a primary goal in treating patients with severe traumatic brain injury (TBI). Secondary brain injury results from tissue ischemia induced by increased vascular resistance in the at-risk brain tissue due to compression by traumatic hematomas, and development of cytotoxic and vasogenic tissue edema. While traumatic hematomas may be managed surgically, cytotoxic and vasogenic edema with resulting perfusion impairment perpetuates brain ischemia and injury. Animal models suggest that remote ischemic conditioning (RIC) can reverse these effects and improve perfusion. Based on these findings it is hypothesized that RIC will exert beneficial effects on TBI in man, thereby representing a new therapeutic strategy for severe TBI.

A teljes eredeti leírásKevesebb

Patients presenting to our institution suffering from severe TBI will be considered for enrollment. Eligible patients will have sustained a blunt, severe TBI (defined by Glasgow Coma Scale <8) with associated intra-cranial hematoma(s) not requiring immediate surgical decompression, with admission to an intensive care unit and insertion of an intra-cranial pressure monitor. Patients will be randomized to RIC versus sham-RIC intervention cohorts. RIC interventions will be performed using an automated device on the upper extremity delivering 20 cumulative minutes of limb ischemia in a single treatment session. The planned enrollment is a cohort of 40 patients.

Outcomes of this study will include multiple domains. Our primary outcome will include serial assessments of validated serum biomarkers of neuronal injury and systemic inflammation. Secondary outcomes will include descriptions of the clinical course of each patient, radiologic assessment of brain perfusion, and neurocognitive and psychological assessment post-discharge.

If clinical outcomes are improved using RIC, this study would support RIC as a novel treatment for TBI. Its advantages include safety and simplicity and, requiring no specialized equipment, its ability to be used in any environment including pre-hospital settings or in austere theatres. The investigators anticipate that TBI patients treated with RIC will have improved clinical, biochemical, and neuropsychological outcomes compared to standard treatment protocols.

A vizsgálat 2 csoportja

  • Control ArmSzínlelt kezelés, összehasonlításként

    Control-arm patients will be treated with standard "Best Practice" management of traumatic brain injury, with the addition of sham-RIC. The sham intervention will use a purpose-built device which will visually and audibly mimic a functional RIC device, with the key distinction being non-inflation of the arm cuff with resultant non-occlusion and no induced ischemia. To mask patient enrollment, all patients in both study arms will have the arm and RIC device draped in an opaque sheet so that the extremity distal to the RIC device are not visible to medical staff during the period of intervention.

    Kezelés: Best Practice Management of Traumatic Brain Injury

  • RIC ArmA vizsgált kezelés

    The RIC treatment will be applied with a purpose-built commercial RIC device which will aid in standardizing dose and delivery. Therapeutic RIC will be provided by the CellAegis Technologies autoRIC device on an upper extremity. As with the control cohort, this cohort will undergo complete extremity draping.

    Kezelés: CellAegis Technologies autoRIC device és Best Practice Management of Traumatic Brain Injury

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury: a Prospective Randomized Controlled Trial.
A regiszteradat frissítve
2024. március 15.